Search for: "Amgen Inc. v. Sanofi"
Results 1 - 20
of 110
Sort by Relevance
|
Sort by Date
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
17 May 2024, 9:37 pm
Cir. 1997) and Epcon Gas Sys., Inc. v. [read post]
26 Apr 2024, 12:41 pm
by Dennis Crouch I was rereading the Supreme Court’s recent enablement decision of Amgen Inc. v. [read post]
23 Apr 2024, 10:28 am
See, Amgen Inc. v. [read post]
18 Jan 2024, 5:14 pm
The post USPTO Issues “Reasonable” Guidance on Enablement Under Amgen v. [read post]
11 Jan 2024, 12:59 pm
Background on Amgen v. [read post]
31 Dec 2023, 4:29 pm
Enablement Amgen v. [read post]
20 Dec 2023, 5:00 am
How Amgen v. [read post]
4 Dec 2023, 10:00 pm
§ 112(a) as it relates to biotechnology and specifically antibody claims, addressed by the Supreme Court in Amgen Inc. v. [read post]
3 Dec 2023, 9:15 am
It seems likely that Amgen Inc. v. [read post]
3 Dec 2023, 9:15 am
It seems likely that Amgen Inc. v. [read post]
29 Nov 2023, 8:41 am
The Federal Circuit rejected this argument based on dicta in Thryv, Inc. v. [read post]
18 Oct 2023, 4:58 pm
In Amgen Inc. v. [read post]
4 Oct 2023, 5:27 pm
As a reminder the SCOTUS in Amgen warned that “the more one claims, the more one must enable” Amgen Inc. v. [read post]
3 Oct 2023, 4:15 am
The Supreme Court decided Amgen Inc. v. [read post]
